This gene was among several susceptibility regions identified in the most recent lung cancer GWAS16, and now we more conclusively establish impaired pulmonary function as the mechanism mediating SECISBP2L effects on risk of lung cancer overall, particularly adenocarcinoma. Here, SECISBP2L is linked to adenocarcinoma.